Patented Technology Aims for Zero Missed Heart Disease Diagnoses; Cocolomil to Present Heart Disease Risk Detection Efforts at Japan's Largest Invitation-Only Conference 'B Dash Camp Pitch Arena'
Cocolomil Inc. has been selected as one of the 12 finalists for the 'Pitch Arena' pitch contest at 'B Dash Camp 2026 Spring in Sapporo,' Japan's largest invitation-only conference. As the only healthcare company among over 150 entries, Cocolomil will present its efforts to achieve zero missed heart disease diagnoses through an integrated system from early detection at home to reliable medical connection, based on its proprietary patented technology.
📋 Article Processing Timeline
- 📰 Published: May 7, 2026 at 23:11
- 🔍 Collected: May 7, 2026 at 14:31
- 🤖 AI Analyzed: May 7, 2026 at 15:49 (1h 17m after Collected)
Cocolomil Inc. (Headquarters: Shinjuku-ku, Tokyo; Representative Director: Daiki Hayashi) has been selected as one of the 12 finalists for the "Pitch Arena" pitch contest at "B Dash Camp 2026 Spring in Sapporo," Japan's largest invitation-only conference. It is the only healthcare company selected from over 150 entries.
At this presentation, based on our independently developed patented technology, we will announce a new social implementation that aims to "save lives that could have been saved" by providing an integrated solution from early detection in daily life (Home Heart Dock pro) to reliable medical connection (eclat).
Why Cocolomil alone can save "lives that could not be saved until now"
Conventional electrocardiogram examinations conducted during health check-ups, lasting only tens of seconds, record less than 0.1% of a day, potentially missing unpredictable signs such as arrhythmias and angina pectoris.
In cases where sudden cardiac death occurs despite a normal health check-up, fatal risks may be hidden during this "unexamined time."
Our company has built a unique scheme to better visualize "heart conditions" and connect individuals to appropriate medical care.
1. [Overwhelming Detection Capability] "Home Heart Dock pro" Visualizes Risks Hidden in Daily Life
Our "Home Heart Dock pro" uses a uniquely developed lightweight patch-type electrocardiograph device that can measure for 9 to 24 hours without restricting daily life.
This visualizes potential risks such as arrhythmias, heart risks, sleep apnea syndrome (SAS) leading to sudden death risk, and signs of stress. The extracted data is analyzed by medical professionals and delivered to users via email in a report.
2. [Medical Connection] Seamless "Discovery" to "Treatment" Last Mile
The results of "Home Heart Dock pro" can be brought to medical institutions for consultation. We also have a complete online clinic, and depending on the diagnosis, we can arrange referral letters to university hospitals. We have established a system where even busy individuals who cannot take time for hospital visits can promptly receive appropriate medical care.
Furthermore, at the medical sites where patients visit, our independently developed medical device "eclat" (Eclat), which has already been introduced to medical institutions nationwide, is available. Eclat is a patch-type device without cumbersome electrode cords for patients, allowing continuous measurement for 7 days while significantly reducing daily life restrictions such as showering.
For hospitals, this "completely disposable" product offers an overwhelming advantage (contribution to work style reform) by completely eliminating ancillary tasks such as collection, cleaning, disinfection, and recharging of equipment, which were essential for conventional examination equipment.
3. Connecting the Baton of Life-Saving through "Daily Screening" and "Connection to Medical Settings"
By integrating daily screening (Home Heart Dock pro) with definitive diagnosis and treatment (eclat) through our own infrastructure, we connect the "baton of life-saving" without burdening both patients and medical settings.
This ecosystem, which integrates "daily screening" and "connection to medical settings" with patented technology, is the biggest reason why Cocolomil can confidently say it will "eliminate sudden death."
Growth Strategy: From Human to Animal Medicine, and Globally
Our technology base is already operating on both fronts: medical settings (eclat) and homes (Home Heart Dock pro). This model has extremely high affinity in the animal medical field, targeting pets that "cannot express their symptoms in words."
At B Dash Camp, we will present a business vision with overwhelming scalability to eliminate sudden death from humans to animals, and across the world.
[Presentation Overview]
■ About B Dash Camp
B Dash Camp is Japan's largest invitation-only conference where executives and prominent figures active in the startup industry gather. Startup executives, listed company officers, venture capitalists, and startup supporters participate, with various programs held over three days, including panel discussions on industry trends, networking among participants, and pitch contests by startups.
■ B Dash Camp 2026 Spring in Sapporo
・Dates: May 20 (Wed) - 22 (Fri), 2026
・Location: Sapporo City
・Organizer: B Dash Ventures Inc.
・Event Website: https://camp.bdashventures.com/sapporo/
Product Overview ①: Completely Disposable Patch-Type Holter ECG "eclat"
Japan's first 7-day measurement completely disposable patch-type, rechargeable for 2 years after manufacturing.
At this presentation, based on our independently developed patented technology, we will announce a new social implementation that aims to "save lives that could have been saved" by providing an integrated solution from early detection in daily life (Home Heart Dock pro) to reliable medical connection (eclat).
Why Cocolomil alone can save "lives that could not be saved until now"
Conventional electrocardiogram examinations conducted during health check-ups, lasting only tens of seconds, record less than 0.1% of a day, potentially missing unpredictable signs such as arrhythmias and angina pectoris.
In cases where sudden cardiac death occurs despite a normal health check-up, fatal risks may be hidden during this "unexamined time."
Our company has built a unique scheme to better visualize "heart conditions" and connect individuals to appropriate medical care.
1. [Overwhelming Detection Capability] "Home Heart Dock pro" Visualizes Risks Hidden in Daily Life
Our "Home Heart Dock pro" uses a uniquely developed lightweight patch-type electrocardiograph device that can measure for 9 to 24 hours without restricting daily life.
This visualizes potential risks such as arrhythmias, heart risks, sleep apnea syndrome (SAS) leading to sudden death risk, and signs of stress. The extracted data is analyzed by medical professionals and delivered to users via email in a report.
2. [Medical Connection] Seamless "Discovery" to "Treatment" Last Mile
The results of "Home Heart Dock pro" can be brought to medical institutions for consultation. We also have a complete online clinic, and depending on the diagnosis, we can arrange referral letters to university hospitals. We have established a system where even busy individuals who cannot take time for hospital visits can promptly receive appropriate medical care.
Furthermore, at the medical sites where patients visit, our independently developed medical device "eclat" (Eclat), which has already been introduced to medical institutions nationwide, is available. Eclat is a patch-type device without cumbersome electrode cords for patients, allowing continuous measurement for 7 days while significantly reducing daily life restrictions such as showering.
For hospitals, this "completely disposable" product offers an overwhelming advantage (contribution to work style reform) by completely eliminating ancillary tasks such as collection, cleaning, disinfection, and recharging of equipment, which were essential for conventional examination equipment.
3. Connecting the Baton of Life-Saving through "Daily Screening" and "Connection to Medical Settings"
By integrating daily screening (Home Heart Dock pro) with definitive diagnosis and treatment (eclat) through our own infrastructure, we connect the "baton of life-saving" without burdening both patients and medical settings.
This ecosystem, which integrates "daily screening" and "connection to medical settings" with patented technology, is the biggest reason why Cocolomil can confidently say it will "eliminate sudden death."
Growth Strategy: From Human to Animal Medicine, and Globally
Our technology base is already operating on both fronts: medical settings (eclat) and homes (Home Heart Dock pro). This model has extremely high affinity in the animal medical field, targeting pets that "cannot express their symptoms in words."
At B Dash Camp, we will present a business vision with overwhelming scalability to eliminate sudden death from humans to animals, and across the world.
[Presentation Overview]
■ About B Dash Camp
B Dash Camp is Japan's largest invitation-only conference where executives and prominent figures active in the startup industry gather. Startup executives, listed company officers, venture capitalists, and startup supporters participate, with various programs held over three days, including panel discussions on industry trends, networking among participants, and pitch contests by startups.
■ B Dash Camp 2026 Spring in Sapporo
・Dates: May 20 (Wed) - 22 (Fri), 2026
・Location: Sapporo City
・Organizer: B Dash Ventures Inc.
・Event Website: https://camp.bdashventures.com/sapporo/
Product Overview ①: Completely Disposable Patch-Type Holter ECG "eclat"
Japan's first 7-day measurement completely disposable patch-type, rechargeable for 2 years after manufacturing.